Skip to main content
. Author manuscript; available in PMC: 2011 Jun 1.
Published in final edited form as: Mol Cancer Ther. 2010 May 18;9(6):1669–1679. doi: 10.1158/1535-7163.MCT-10-0023

Table 2. Characteristics of the Ribonucleotide Reductase Small Subunits Proteins.

Ribonucleotide Reductase activity was presented as formation of dCDP (see Materials and Methods), and was measured in the presence of 0.059 μM (5 μg) of R1 protein and 0.057 μM (2.5 μg) of hRRM2 or hp53R2 proteins with a total sample volume of 100 μl. Each value is the average of two to three determinations with deviations < 0.3. ND: not detectable. Iron quantification is performed on freshly purified protein using atomic absorption spectrometry with lower limit > 0.01. The radical content was quantified against a standard solution of 1mmol/L CuSO4 in 50mmol/L EDTA by double integration of spectra registered at no saturating microwave levels using standard Bruker method. The lowest limit of detection is 0.001.

Proteins Specific Activity (nmol/min/mg R2) Iron Content (mol/mol R2, %) Radical Content (mol/mol R2)
hp5 3R2
wild type 4152 ± 96 1.53 ± 0.26 100 0.82
F183Y 4592 ± 176 1.82 ± 0.27 119 0.90
Y124W 1352 ± 104 0.84 ± 0.10 55 0.27
Y124W/F183Y 192 ± 24 0.56 ± 0.07 37 0.04
Q127V 384 ± 88 0.40 ± 0.16 26 0.08
Q127K ND 0.24 ± 0.11 16 ND
Q127E 376 ± 24 0.68 ± 0.12 44 0.07
Q127N 160 ± 48 0.80 ± 0.02 52 0.03
hRRM2
wild type 6000 ± 96 3.10 ± 0.58 100 1.23
Y221F 4456 ± 248 1.45 ± 0.42 47 0.91
Y162W 208 ± 16 0.72 ± 0.13 23 0.04
Y162W/Y221F 1304 ± 152 0.95 ± 0.07 31 0.27
Q165V 232 ± 48 0.62 ± 0.14 20 0.05
Q165K ND 0.34 ± 0.04 11 ND
Q165E 480 ± 136 0.70 ± 0.12 22 0.10
Q165N 400 ± 24 0.50 ± 0.06 16 0.08